nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—Methylprednisolone—multiple sclerosis	0.144	0.357	CrCtD
Ciclesonide—Prednisone—multiple sclerosis	0.131	0.326	CrCtD
Ciclesonide—Prednisolone—multiple sclerosis	0.128	0.318	CrCtD
Ciclesonide—SERPINA6—Triamcinolone—multiple sclerosis	0.0457	0.195	CbGbCtD
Ciclesonide—SERPINA6—Prednisolone—multiple sclerosis	0.0387	0.165	CbGbCtD
Ciclesonide—NR3C1—Methylprednisolone—multiple sclerosis	0.0282	0.12	CbGbCtD
Ciclesonide—NR3C1—Triamcinolone—multiple sclerosis	0.0214	0.0909	CbGbCtD
Ciclesonide—NR3C1—Betamethasone—multiple sclerosis	0.0183	0.078	CbGbCtD
Ciclesonide—NR3C1—Prednisolone—multiple sclerosis	0.0181	0.077	CbGbCtD
Ciclesonide—NR3C1—Prednisone—multiple sclerosis	0.0171	0.0727	CbGbCtD
Ciclesonide—NR3C1—Dexamethasone—multiple sclerosis	0.0107	0.0454	CbGbCtD
Ciclesonide—CYP2D6—Fingolimod—multiple sclerosis	0.0096	0.0409	CbGbCtD
Ciclesonide—CYP3A4—Fingolimod—multiple sclerosis	0.0061	0.026	CbGbCtD
Ciclesonide—CYP3A4—Methylprednisolone—multiple sclerosis	0.00393	0.0167	CbGbCtD
Ciclesonide—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00382	0.0122	CrCrCtD
Ciclesonide—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00376	0.012	CrCrCtD
Ciclesonide—Flurandrenolide—Betamethasone—multiple sclerosis	0.00376	0.012	CrCrCtD
Ciclesonide—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00358	0.0114	CrCrCtD
Ciclesonide—Flurandrenolide—Prednisolone—multiple sclerosis	0.00341	0.0109	CrCrCtD
Ciclesonide—Testolactone—Methylprednisolone—multiple sclerosis	0.00336	0.0108	CrCrCtD
Ciclesonide—Fluocinonide—Methylprednisolone—multiple sclerosis	0.00336	0.0108	CrCrCtD
Ciclesonide—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00336	0.0108	CrCrCtD
Ciclesonide—Prednicarbate—Betamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Fluocinonide—Betamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Fluocinonide—Dexamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Beclomethasone—Dexamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Testolactone—Betamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Testolactone—Dexamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Prednicarbate—Dexamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Beclomethasone—Betamethasone—multiple sclerosis	0.00331	0.0106	CrCrCtD
Ciclesonide—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00327	0.0105	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisone—multiple sclerosis	0.00326	0.0104	CrCrCtD
Ciclesonide—Testolactone—Triamcinolone—multiple sclerosis	0.00323	0.0104	CrCrCtD
Ciclesonide—Fluocinonide—Triamcinolone—multiple sclerosis	0.00323	0.0104	CrCrCtD
Ciclesonide—Beclomethasone—Triamcinolone—multiple sclerosis	0.00323	0.0104	CrCrCtD
Ciclesonide—Prednicarbate—Triamcinolone—multiple sclerosis	0.00323	0.0104	CrCrCtD
Ciclesonide—Fluocortolone—Betamethasone—multiple sclerosis	0.00322	0.0103	CrCrCtD
Ciclesonide—Fluocortolone—Dexamethasone—multiple sclerosis	0.00322	0.0103	CrCrCtD
Ciclesonide—Hydrocortamate—Prednisolone—multiple sclerosis	0.00319	0.0102	CrCrCtD
Ciclesonide—Alclometasone—Methylprednisolone—multiple sclerosis	0.00318	0.0102	CrCrCtD
Ciclesonide—Fluocortolone—Triamcinolone—multiple sclerosis	0.00314	0.0101	CrCrCtD
Ciclesonide—Alclometasone—Dexamethasone—multiple sclerosis	0.00313	0.01	CrCrCtD
Ciclesonide—Alclometasone—Betamethasone—multiple sclerosis	0.00313	0.01	CrCrCtD
Ciclesonide—Budesonide—Methylprednisolone—multiple sclerosis	0.00309	0.00989	CrCrCtD
Ciclesonide—Prednicarbate—Prednisone—multiple sclerosis	0.00307	0.00982	CrCrCtD
Ciclesonide—Testolactone—Prednisone—multiple sclerosis	0.00307	0.00982	CrCrCtD
Ciclesonide—Alclometasone—Triamcinolone—multiple sclerosis	0.00305	0.00978	CrCrCtD
Ciclesonide—Amcinonide—Betamethasone—multiple sclerosis	0.00304	0.00974	CrCrCtD
Ciclesonide—Budesonide—Betamethasone—multiple sclerosis	0.00304	0.00974	CrCrCtD
Ciclesonide—Amcinonide—Dexamethasone—multiple sclerosis	0.00304	0.00974	CrCrCtD
Ciclesonide—Budesonide—Dexamethasone—multiple sclerosis	0.00304	0.00974	CrCrCtD
Ciclesonide—Flunisolide—Methylprednisolone—multiple sclerosis	0.00301	0.00964	CrCrCtD
Ciclesonide—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00301	0.00964	CrCrCtD
Ciclesonide—Prednisone—Methylprednisolone—multiple sclerosis	0.00301	0.00964	CrCrCtD
Ciclesonide—Desonide—Methylprednisolone—multiple sclerosis	0.00301	0.00964	CrCrCtD
Ciclesonide—Testolactone—Prednisolone—multiple sclerosis	0.003	0.00959	CrCrCtD
Ciclesonide—Prednicarbate—Prednisolone—multiple sclerosis	0.003	0.00959	CrCrCtD
Ciclesonide—Beclomethasone—Prednisolone—multiple sclerosis	0.003	0.00959	CrCrCtD
Ciclesonide—Fluocortolone—Prednisone—multiple sclerosis	0.00298	0.00954	CrCrCtD
Ciclesonide—CYP3A4—Triamcinolone—multiple sclerosis	0.00298	0.0127	CbGbCtD
Ciclesonide—Budesonide—Triamcinolone—multiple sclerosis	0.00297	0.00952	CrCrCtD
Ciclesonide—Amcinonide—Triamcinolone—multiple sclerosis	0.00297	0.00952	CrCrCtD
Ciclesonide—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Desonide—Betamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Prednisone—Betamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Clobetasol propionate—Betamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Prednisone—Dexamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Flunisolide—Dexamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Flunisolide—Betamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Desonide—Dexamethasone—multiple sclerosis	0.00296	0.00949	CrCrCtD
Ciclesonide—Paramethasone—Methylprednisolone—multiple sclerosis	0.00294	0.0094	CrCrCtD
Ciclesonide—Fluocortolone—Prednisolone—multiple sclerosis	0.00291	0.00931	CrCrCtD
Ciclesonide—Alclometasone—Prednisone—multiple sclerosis	0.0029	0.00928	CrCrCtD
Ciclesonide—Desonide—Triamcinolone—multiple sclerosis	0.0029	0.00927	CrCrCtD
Ciclesonide—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.0029	0.00927	CrCrCtD
Ciclesonide—Flunisolide—Triamcinolone—multiple sclerosis	0.0029	0.00927	CrCrCtD
Ciclesonide—Prednisone—Triamcinolone—multiple sclerosis	0.0029	0.00927	CrCrCtD
Ciclesonide—Paramethasone—Betamethasone—multiple sclerosis	0.00289	0.00925	CrCrCtD
Ciclesonide—Paramethasone—Dexamethasone—multiple sclerosis	0.00289	0.00925	CrCrCtD
Ciclesonide—CYP3A4—Mitoxantrone—multiple sclerosis	0.00287	0.0122	CbGbCtD
Ciclesonide—Alclometasone—Prednisolone—multiple sclerosis	0.00283	0.00906	CrCrCtD
Ciclesonide—Paramethasone—Triamcinolone—multiple sclerosis	0.00282	0.00904	CrCrCtD
Ciclesonide—Budesonide—Prednisone—multiple sclerosis	0.00282	0.00903	CrCrCtD
Ciclesonide—Amcinonide—Prednisone—multiple sclerosis	0.00282	0.00903	CrCrCtD
Ciclesonide—Loteprednol—Methylprednisolone—multiple sclerosis	0.0028	0.00895	CrCrCtD
Ciclesonide—Amcinonide—Prednisolone—multiple sclerosis	0.00275	0.00881	CrCrCtD
Ciclesonide—Budesonide—Prednisolone—multiple sclerosis	0.00275	0.00881	CrCrCtD
Ciclesonide—Loteprednol—Dexamethasone—multiple sclerosis	0.00275	0.00881	CrCrCtD
Ciclesonide—Loteprednol—Betamethasone—multiple sclerosis	0.00275	0.00881	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisone—multiple sclerosis	0.00275	0.0088	CrCrCtD
Ciclesonide—Desonide—Prednisone—multiple sclerosis	0.00275	0.0088	CrCrCtD
Ciclesonide—Flunisolide—Prednisone—multiple sclerosis	0.00275	0.0088	CrCrCtD
Ciclesonide—Rimexolone—Methylprednisolone—multiple sclerosis	0.00273	0.00875	CrCrCtD
Ciclesonide—Rimexolone—Betamethasone—multiple sclerosis	0.00269	0.00861	CrCrCtD
Ciclesonide—Rimexolone—Dexamethasone—multiple sclerosis	0.00269	0.00861	CrCrCtD
Ciclesonide—Loteprednol—Triamcinolone—multiple sclerosis	0.00269	0.00861	CrCrCtD
Ciclesonide—Flunisolide—Prednisolone—multiple sclerosis	0.00268	0.00859	CrCrCtD
Ciclesonide—Prednisone—Prednisolone—multiple sclerosis	0.00268	0.00859	CrCrCtD
Ciclesonide—Desonide—Prednisolone—multiple sclerosis	0.00268	0.00859	CrCrCtD
Ciclesonide—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00268	0.00859	CrCrCtD
Ciclesonide—Paramethasone—Prednisone—multiple sclerosis	0.00268	0.00858	CrCrCtD
Ciclesonide—Rimexolone—Triamcinolone—multiple sclerosis	0.00263	0.00841	CrCrCtD
Ciclesonide—Paramethasone—Prednisolone—multiple sclerosis	0.00262	0.00837	CrCrCtD
Ciclesonide—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00257	0.00823	CrCrCtD
Ciclesonide—Methylprednisolone—Betamethasone—multiple sclerosis	0.00257	0.00823	CrCrCtD
Ciclesonide—Prednisolone—Methylprednisolone—multiple sclerosis	0.00256	0.00819	CrCrCtD
Ciclesonide—CYP3A4—Betamethasone—multiple sclerosis	0.00256	0.0109	CbGbCtD
Ciclesonide—Loteprednol—Prednisone—multiple sclerosis	0.00255	0.00817	CrCrCtD
Ciclesonide—CYP3A4—Prednisolone—multiple sclerosis	0.00252	0.0107	CbGbCtD
Ciclesonide—Prednisolone—Dexamethasone—multiple sclerosis	0.00252	0.00806	CrCrCtD
Ciclesonide—Prednisolone—Betamethasone—multiple sclerosis	0.00252	0.00806	CrCrCtD
Ciclesonide—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00251	0.00805	CrCrCtD
Ciclesonide—Rimexolone—Prednisone—multiple sclerosis	0.00249	0.00798	CrCrCtD
Ciclesonide—Loteprednol—Prednisolone—multiple sclerosis	0.00249	0.00797	CrCrCtD
Ciclesonide—Prednisolone—Triamcinolone—multiple sclerosis	0.00246	0.00788	CrCrCtD
Ciclesonide—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00246	0.00786	CrCrCtD
Ciclesonide—Rimexolone—Prednisolone—multiple sclerosis	0.00243	0.00779	CrCrCtD
Ciclesonide—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00242	0.00774	CrCrCtD
Ciclesonide—Hydrocortisone—Betamethasone—multiple sclerosis	0.00242	0.00774	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisone—multiple sclerosis	0.00239	0.00764	CrCrCtD
Ciclesonide—CYP3A4—Prednisone—multiple sclerosis	0.00238	0.0101	CbGbCtD
Ciclesonide—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00236	0.00756	CrCrCtD
Ciclesonide—CYP2D6—Dexamethasone—multiple sclerosis	0.00234	0.00996	CbGbCtD
Ciclesonide—Prednisolone—Prednisone—multiple sclerosis	0.00234	0.00747	CrCrCtD
Ciclesonide—Methylprednisolone—Prednisolone—multiple sclerosis	0.00233	0.00745	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisone—multiple sclerosis	0.00224	0.00717	CrCrCtD
Ciclesonide—Hydrocortisone—Prednisolone—multiple sclerosis	0.00219	0.007	CrCrCtD
Ciclesonide—CYP3A4—Dexamethasone—multiple sclerosis	0.00149	0.00633	CbGbCtD
Ciclesonide—CES1—Phase I biotransformations, non P450—PON1—multiple sclerosis	0.00142	0.254	CbGpPWpGaD
Ciclesonide—CES1—Irinotecan Pathway—BCHE—multiple sclerosis	0.000431	0.0773	CbGpPWpGaD
Ciclesonide—CES1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000378	0.0677	CbGpPWpGaD
Ciclesonide—CES1—E2F transcription factor network—RRM1—multiple sclerosis	0.0002	0.0359	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000194	0.0348	CbGpPWpGaD
Ciclesonide—Multiple fractures—Methotrexate—multiple sclerosis	0.000166	0.00373	CcSEcCtD
Ciclesonide—Pneumonia—Cladribine—multiple sclerosis	0.000166	0.00373	CcSEcCtD
Ciclesonide—Dyspnoea—Fingolimod—multiple sclerosis	0.000166	0.00372	CcSEcCtD
Ciclesonide—Infestation NOS—Cladribine—multiple sclerosis	0.000165	0.00371	CcSEcCtD
Ciclesonide—Infestation—Cladribine—multiple sclerosis	0.000165	0.00371	CcSEcCtD
Ciclesonide—Oropharyngeal pain—Triamcinolone—multiple sclerosis	0.000161	0.00361	CcSEcCtD
Ciclesonide—Urinary tract infection—Cladribine—multiple sclerosis	0.000161	0.0036	CcSEcCtD
Ciclesonide—Conjunctivitis—Cladribine—multiple sclerosis	0.000161	0.0036	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000161	0.0036	CcSEcCtD
Ciclesonide—Fatigue—Fingolimod—multiple sclerosis	0.00016	0.0036	CcSEcCtD
Ciclesonide—Swelling—Mitoxantrone—multiple sclerosis	0.00016	0.00358	CcSEcCtD
Ciclesonide—Epistaxis—Cladribine—multiple sclerosis	0.000156	0.0035	CcSEcCtD
Ciclesonide—Ulcer—Triamcinolone—multiple sclerosis	0.000155	0.00347	CcSEcCtD
Ciclesonide—Cataract—Triamcinolone—multiple sclerosis	0.000154	0.00345	CcSEcCtD
Ciclesonide—Contusion—Betamethasone—multiple sclerosis	0.000152	0.00342	CcSEcCtD
Ciclesonide—Contusion—Dexamethasone—multiple sclerosis	0.000152	0.00342	CcSEcCtD
Ciclesonide—Haemoglobin—Cladribine—multiple sclerosis	0.000149	0.00334	CcSEcCtD
Ciclesonide—Haemorrhage—Cladribine—multiple sclerosis	0.000148	0.00333	CcSEcCtD
Ciclesonide—Pharyngitis—Cladribine—multiple sclerosis	0.000147	0.0033	CcSEcCtD
Ciclesonide—Wheezing—Triamcinolone—multiple sclerosis	0.000142	0.00319	CcSEcCtD
Ciclesonide—Ulcer—Dexamethasone—multiple sclerosis	0.000141	0.00315	CcSEcCtD
Ciclesonide—Ulcer—Betamethasone—multiple sclerosis	0.000141	0.00315	CcSEcCtD
Ciclesonide—Candida infection—Triamcinolone—multiple sclerosis	0.00014	0.00314	CcSEcCtD
Ciclesonide—Cataract—Betamethasone—multiple sclerosis	0.00014	0.00313	CcSEcCtD
Ciclesonide—Cataract—Dexamethasone—multiple sclerosis	0.00014	0.00313	CcSEcCtD
Ciclesonide—Pneumonia—Azathioprine—multiple sclerosis	0.000135	0.00303	CcSEcCtD
Ciclesonide—Infestation NOS—Azathioprine—multiple sclerosis	0.000134	0.00301	CcSEcCtD
Ciclesonide—Infestation—Azathioprine—multiple sclerosis	0.000134	0.00301	CcSEcCtD
Ciclesonide—Immune system disorder—Cladribine—multiple sclerosis	0.000134	0.00301	CcSEcCtD
Ciclesonide—Mediastinal disorder—Cladribine—multiple sclerosis	0.000134	0.003	CcSEcCtD
Ciclesonide—Asthenia—Fingolimod—multiple sclerosis	0.000133	0.00299	CcSEcCtD
Ciclesonide—Diabetes mellitus—Prednisolone—multiple sclerosis	0.000133	0.00298	CcSEcCtD
Ciclesonide—Contusion—Prednisone—multiple sclerosis	0.000133	0.00298	CcSEcCtD
Ciclesonide—Back pain—Cladribine—multiple sclerosis	0.000125	0.0028	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000124	0.00279	CcSEcCtD
Ciclesonide—Dizziness—Fingolimod—multiple sclerosis	0.000123	0.00276	CcSEcCtD
Ciclesonide—Ulcer—Prednisone—multiple sclerosis	0.000122	0.00275	CcSEcCtD
Ciclesonide—Diabetes mellitus—Triamcinolone—multiple sclerosis	0.000122	0.00274	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methylprednisolone—multiple sclerosis	0.000122	0.00274	CcSEcCtD
Ciclesonide—Cataract—Prednisone—multiple sclerosis	0.000122	0.00273	CcSEcCtD
Ciclesonide—Haemoglobin—Azathioprine—multiple sclerosis	0.000121	0.00272	CcSEcCtD
Ciclesonide—Haemorrhage—Azathioprine—multiple sclerosis	0.000121	0.00271	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000117	0.0211	CbGpPWpGaD
Ciclesonide—Headache—Fingolimod—multiple sclerosis	0.000116	0.00261	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.000113	0.00254	CcSEcCtD
Ciclesonide—Cough—Cladribine—multiple sclerosis	0.000113	0.00253	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.000111	0.02	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.000111	0.02	CbGpPWpGaD
Ciclesonide—Diabetes mellitus—Betamethasone—multiple sclerosis	0.000111	0.00249	CcSEcCtD
Ciclesonide—Diabetes mellitus—Dexamethasone—multiple sclerosis	0.000111	0.00249	CcSEcCtD
Ciclesonide—Weight increased—Mitoxantrone—multiple sclerosis	0.000111	0.00249	CcSEcCtD
Ciclesonide—Arthralgia—Cladribine—multiple sclerosis	0.00011	0.00247	CcSEcCtD
Ciclesonide—Chest pain—Cladribine—multiple sclerosis	0.00011	0.00247	CcSEcCtD
Ciclesonide—Pneumonia—Mitoxantrone—multiple sclerosis	0.000109	0.00245	CcSEcCtD
Ciclesonide—Immune system disorder—Azathioprine—multiple sclerosis	0.000109	0.00244	CcSEcCtD
Ciclesonide—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000109	0.00244	CcSEcCtD
Ciclesonide—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.000106	0.00237	CcSEcCtD
Ciclesonide—Conjunctivitis—Mitoxantrone—multiple sclerosis	0.000106	0.00237	CcSEcCtD
Ciclesonide—Infection—Cladribine—multiple sclerosis	0.000105	0.00235	CcSEcCtD
Ciclesonide—Ulcer—Methotrexate—multiple sclerosis	0.000102	0.00229	CcSEcCtD
Ciclesonide—Sinusitis—Mitoxantrone—multiple sclerosis	0.000102	0.00229	CcSEcCtD
Ciclesonide—Haemoglobin—Mitoxantrone—multiple sclerosis	9.8e-05	0.0022	CcSEcCtD
Ciclesonide—Rhinitis—Mitoxantrone—multiple sclerosis	9.78e-05	0.00219	CcSEcCtD
Ciclesonide—Haemorrhage—Mitoxantrone—multiple sclerosis	9.75e-05	0.00219	CcSEcCtD
Ciclesonide—Pharyngitis—Mitoxantrone—multiple sclerosis	9.68e-05	0.00217	CcSEcCtD
Ciclesonide—Diabetes mellitus—Prednisone—multiple sclerosis	9.66e-05	0.00217	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Cladribine—multiple sclerosis	9.6e-05	0.00215	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	9.6e-05	0.0172	CbGpPWpGaD
Ciclesonide—Dyspnoea—Cladribine—multiple sclerosis	9.4e-05	0.00211	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	9.36e-05	0.0021	CcSEcCtD
Ciclesonide—Influenza—Triamcinolone—multiple sclerosis	9.19e-05	0.00206	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Cladribine—multiple sclerosis	9.1e-05	0.00204	CcSEcCtD
Ciclesonide—Weight increased—Prednisolone—multiple sclerosis	9.1e-05	0.00204	CcSEcCtD
Ciclesonide—Fatigue—Cladribine—multiple sclerosis	9.09e-05	0.00204	CcSEcCtD
Ciclesonide—Bronchospasm—Methylprednisolone—multiple sclerosis	9.02e-05	0.00202	CcSEcCtD
Ciclesonide—Arthralgia—Azathioprine—multiple sclerosis	8.94e-05	0.00201	CcSEcCtD
Ciclesonide—Bronchitis—Triamcinolone—multiple sclerosis	8.84e-05	0.00198	CcSEcCtD
Ciclesonide—Conjunctivitis—Prednisolone—multiple sclerosis	8.66e-05	0.00194	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	8.54e-05	0.00192	CcSEcCtD
Ciclesonide—Infection—Azathioprine—multiple sclerosis	8.51e-05	0.00191	CcSEcCtD
Ciclesonide—Urticaria—Cladribine—multiple sclerosis	8.37e-05	0.00188	CcSEcCtD
Ciclesonide—Weight increased—Triamcinolone—multiple sclerosis	8.36e-05	0.00188	CcSEcCtD
Ciclesonide—Weight increased—Methylprednisolone—multiple sclerosis	8.35e-05	0.00187	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	8.31e-05	0.0149	CbGpPWpGaD
Ciclesonide—Dysgeusia—Mitoxantrone—multiple sclerosis	8.31e-05	0.00186	CcSEcCtD
Ciclesonide—Back pain—Mitoxantrone—multiple sclerosis	8.21e-05	0.00184	CcSEcCtD
Ciclesonide—Infestation NOS—Methylprednisolone—multiple sclerosis	8.18e-05	0.00183	CcSEcCtD
Ciclesonide—Infestation—Methylprednisolone—multiple sclerosis	8.18e-05	0.00183	CcSEcCtD
Ciclesonide—Face oedema—Prednisone—multiple sclerosis	8.11e-05	0.00182	CcSEcCtD
Ciclesonide—Diabetes mellitus—Methotrexate—multiple sclerosis	8.07e-05	0.00181	CcSEcCtD
Ciclesonide—Haemoglobin—Prednisolone—multiple sclerosis	8.04e-05	0.0018	CcSEcCtD
Ciclesonide—Haemorrhage—Prednisolone—multiple sclerosis	8e-05	0.00179	CcSEcCtD
Ciclesonide—Conjunctivitis—Triamcinolone—multiple sclerosis	7.97e-05	0.00179	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	7.81e-05	0.00175	CcSEcCtD
Ciclesonide—Epistaxis—Triamcinolone—multiple sclerosis	7.73e-05	0.00173	CcSEcCtD
Ciclesonide—Weight increased—Betamethasone—multiple sclerosis	7.59e-05	0.0017	CcSEcCtD
Ciclesonide—Weight increased—Dexamethasone—multiple sclerosis	7.59e-05	0.0017	CcSEcCtD
Ciclesonide—Asthenia—Cladribine—multiple sclerosis	7.56e-05	0.0017	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Prednisone—multiple sclerosis	7.41e-05	0.00166	CcSEcCtD
Ciclesonide—Cough—Mitoxantrone—multiple sclerosis	7.41e-05	0.00166	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Azathioprine—multiple sclerosis	7.4e-05	0.00166	CcSEcCtD
Ciclesonide—Haemoglobin—Triamcinolone—multiple sclerosis	7.39e-05	0.00166	CcSEcCtD
Ciclesonide—Haemoglobin—Methylprednisolone—multiple sclerosis	7.38e-05	0.00166	CcSEcCtD
Ciclesonide—Rhinitis—Triamcinolone—multiple sclerosis	7.38e-05	0.00165	CcSEcCtD
Ciclesonide—Rhinitis—Methylprednisolone—multiple sclerosis	7.36e-05	0.00165	CcSEcCtD
Ciclesonide—Haemorrhage—Triamcinolone—multiple sclerosis	7.36e-05	0.00165	CcSEcCtD
Ciclesonide—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	7.35e-05	0.0132	CbGpPWpGaD
Ciclesonide—Haemorrhage—Methylprednisolone—multiple sclerosis	7.34e-05	0.00165	CcSEcCtD
Ciclesonide—Hypertension—Mitoxantrone—multiple sclerosis	7.33e-05	0.00164	CcSEcCtD
Ciclesonide—Pharyngitis—Triamcinolone—multiple sclerosis	7.3e-05	0.00164	CcSEcCtD
Ciclesonide—Conjunctivitis—Betamethasone—multiple sclerosis	7.23e-05	0.00162	CcSEcCtD
Ciclesonide—Conjunctivitis—Dexamethasone—multiple sclerosis	7.23e-05	0.00162	CcSEcCtD
Ciclesonide—Arthralgia—Mitoxantrone—multiple sclerosis	7.23e-05	0.00162	CcSEcCtD
Ciclesonide—Chest pain—Mitoxantrone—multiple sclerosis	7.23e-05	0.00162	CcSEcCtD
Ciclesonide—Dizziness—Cladribine—multiple sclerosis	6.97e-05	0.00156	CcSEcCtD
Ciclesonide—Infection—Mitoxantrone—multiple sclerosis	6.88e-05	0.00154	CcSEcCtD
Ciclesonide—Haemoglobin—Betamethasone—multiple sclerosis	6.71e-05	0.00151	CcSEcCtD
Ciclesonide—Haemoglobin—Dexamethasone—multiple sclerosis	6.71e-05	0.00151	CcSEcCtD
Ciclesonide—Haemorrhage—Betamethasone—multiple sclerosis	6.68e-05	0.0015	CcSEcCtD
Ciclesonide—Haemorrhage—Dexamethasone—multiple sclerosis	6.68e-05	0.0015	CcSEcCtD
Ciclesonide—Rash—Cladribine—multiple sclerosis	6.65e-05	0.00149	CcSEcCtD
Ciclesonide—Dermatitis—Cladribine—multiple sclerosis	6.64e-05	0.00149	CcSEcCtD
Ciclesonide—Immune system disorder—Methylprednisolone—multiple sclerosis	6.63e-05	0.00149	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methylprednisolone—multiple sclerosis	6.62e-05	0.00148	CcSEcCtD
Ciclesonide—Weight increased—Prednisone—multiple sclerosis	6.61e-05	0.00148	CcSEcCtD
Ciclesonide—Headache—Cladribine—multiple sclerosis	6.6e-05	0.00148	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	6.57e-05	0.0118	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	6.42e-05	0.0115	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	6.42e-05	0.0115	CbGpPWpGaD
Ciclesonide—Angioedema—Prednisolone—multiple sclerosis	6.36e-05	0.00143	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	6.31e-05	0.00142	CcSEcCtD
Ciclesonide—Dysgeusia—Triamcinolone—multiple sclerosis	6.27e-05	0.00141	CcSEcCtD
Ciclesonide—Nausea—Cladribine—multiple sclerosis	6.26e-05	0.0014	CcSEcCtD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.24e-05	0.0112	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.24e-05	0.0112	CbGpPWpGaD
Ciclesonide—Back pain—Triamcinolone—multiple sclerosis	6.19e-05	0.00139	CcSEcCtD
Ciclesonide—Dyspnoea—Mitoxantrone—multiple sclerosis	6.18e-05	0.00139	CcSEcCtD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.16e-05	0.011	CbGpPWpGaD
Ciclesonide—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.16e-05	0.011	CbGpPWpGaD
Ciclesonide—Dyspepsia—Mitoxantrone—multiple sclerosis	6.1e-05	0.00137	CcSEcCtD
Ciclesonide—Hypertension—Prednisolone—multiple sclerosis	6.01e-05	0.00135	CcSEcCtD
Ciclesonide—Fatigue—Mitoxantrone—multiple sclerosis	5.97e-05	0.00134	CcSEcCtD
Ciclesonide—Angioedema—Triamcinolone—multiple sclerosis	5.85e-05	0.00131	CcSEcCtD
Ciclesonide—Haemoglobin—Prednisone—multiple sclerosis	5.84e-05	0.00131	CcSEcCtD
Ciclesonide—Angioedema—Methylprednisolone—multiple sclerosis	5.84e-05	0.00131	CcSEcCtD
Ciclesonide—Haemorrhage—Prednisone—multiple sclerosis	5.81e-05	0.0013	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	5.81e-05	0.0104	CbGpPWpGaD
Ciclesonide—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	5.69e-05	0.0102	CbGpPWpGaD
Ciclesonide—Dizziness—Azathioprine—multiple sclerosis	5.67e-05	0.00127	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Methotrexate—multiple sclerosis	5.64e-05	0.00127	CcSEcCtD
Ciclesonide—Cough—Triamcinolone—multiple sclerosis	5.59e-05	0.00125	CcSEcCtD
Ciclesonide—Hypertension—Triamcinolone—multiple sclerosis	5.53e-05	0.00124	CcSEcCtD
Ciclesonide—Hypertension—Methylprednisolone—multiple sclerosis	5.52e-05	0.00124	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	5.51e-05	0.00988	CbGpPWpGaD
Ciclesonide—Urticaria—Mitoxantrone—multiple sclerosis	5.5e-05	0.00123	CcSEcCtD
Ciclesonide—Pneumonia—Methotrexate—multiple sclerosis	5.44e-05	0.00122	CcSEcCtD
Ciclesonide—Arthralgia—Methylprednisolone—multiple sclerosis	5.44e-05	0.00122	CcSEcCtD
Ciclesonide—Infestation—Methotrexate—multiple sclerosis	5.41e-05	0.00121	CcSEcCtD
Ciclesonide—Infestation NOS—Methotrexate—multiple sclerosis	5.41e-05	0.00121	CcSEcCtD
Ciclesonide—Rash—Azathioprine—multiple sclerosis	5.4e-05	0.00121	CcSEcCtD
Ciclesonide—Dermatitis—Azathioprine—multiple sclerosis	5.4e-05	0.00121	CcSEcCtD
Ciclesonide—Headache—Azathioprine—multiple sclerosis	5.37e-05	0.0012	CcSEcCtD
Ciclesonide—Dry mouth—Triamcinolone—multiple sclerosis	5.33e-05	0.0012	CcSEcCtD
Ciclesonide—Angioedema—Betamethasone—multiple sclerosis	5.31e-05	0.00119	CcSEcCtD
Ciclesonide—Angioedema—Dexamethasone—multiple sclerosis	5.31e-05	0.00119	CcSEcCtD
Ciclesonide—Conjunctivitis—Methotrexate—multiple sclerosis	5.26e-05	0.00118	CcSEcCtD
Ciclesonide—Immune system disorder—Prednisone—multiple sclerosis	5.25e-05	0.00118	CcSEcCtD
Ciclesonide—Infection—Triamcinolone—multiple sclerosis	5.19e-05	0.00116	CcSEcCtD
Ciclesonide—Infection—Methylprednisolone—multiple sclerosis	5.18e-05	0.00116	CcSEcCtD
Ciclesonide—Epistaxis—Methotrexate—multiple sclerosis	5.1e-05	0.00115	CcSEcCtD
Ciclesonide—Nausea—Azathioprine—multiple sclerosis	5.09e-05	0.00114	CcSEcCtD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.06e-05	0.00906	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.06e-05	0.00906	CbGpPWpGaD
Ciclesonide—Hypertension—Betamethasone—multiple sclerosis	5.02e-05	0.00113	CcSEcCtD
Ciclesonide—Hypertension—Dexamethasone—multiple sclerosis	5.02e-05	0.00113	CcSEcCtD
Ciclesonide—Asthenia—Mitoxantrone—multiple sclerosis	4.97e-05	0.00112	CcSEcCtD
Ciclesonide—Haemoglobin—Methotrexate—multiple sclerosis	4.88e-05	0.0011	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	4.88e-05	0.00874	CbGpPWpGaD
Ciclesonide—Haemorrhage—Methotrexate—multiple sclerosis	4.86e-05	0.00109	CcSEcCtD
Ciclesonide—Pharyngitis—Methotrexate—multiple sclerosis	4.82e-05	0.00108	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	4.76e-05	0.00107	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	4.75e-05	0.00107	CcSEcCtD
Ciclesonide—Infection—Betamethasone—multiple sclerosis	4.71e-05	0.00106	CcSEcCtD
Ciclesonide—Infection—Dexamethasone—multiple sclerosis	4.71e-05	0.00106	CcSEcCtD
Ciclesonide—Dyspnoea—Triamcinolone—multiple sclerosis	4.66e-05	0.00105	CcSEcCtD
Ciclesonide—Angioedema—Prednisone—multiple sclerosis	4.62e-05	0.00104	CcSEcCtD
Ciclesonide—Dyspepsia—Triamcinolone—multiple sclerosis	4.6e-05	0.00103	CcSEcCtD
Ciclesonide—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	4.59e-05	0.00823	CbGpPWpGaD
Ciclesonide—Dyspepsia—Methylprednisolone—multiple sclerosis	4.59e-05	0.00103	CcSEcCtD
Ciclesonide—Urticaria—Prednisolone—multiple sclerosis	4.52e-05	0.00101	CcSEcCtD
Ciclesonide—Fatigue—Triamcinolone—multiple sclerosis	4.51e-05	0.00101	CcSEcCtD
Ciclesonide—Fatigue—Methylprednisolone—multiple sclerosis	4.5e-05	0.00101	CcSEcCtD
Ciclesonide—Immune system disorder—Methotrexate—multiple sclerosis	4.39e-05	0.000984	CcSEcCtD
Ciclesonide—Mediastinal disorder—Methotrexate—multiple sclerosis	4.38e-05	0.000982	CcSEcCtD
Ciclesonide—Hypertension—Prednisone—multiple sclerosis	4.37e-05	0.00098	CcSEcCtD
Ciclesonide—Rash—Mitoxantrone—multiple sclerosis	4.37e-05	0.00098	CcSEcCtD
Ciclesonide—Dermatitis—Mitoxantrone—multiple sclerosis	4.36e-05	0.000979	CcSEcCtD
Ciclesonide—Headache—Mitoxantrone—multiple sclerosis	4.34e-05	0.000974	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.32e-05	0.000969	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.32e-05	0.000969	CcSEcCtD
Ciclesonide—Arthralgia—Prednisone—multiple sclerosis	4.31e-05	0.000966	CcSEcCtD
Ciclesonide—Dyspepsia—Betamethasone—multiple sclerosis	4.17e-05	0.000936	CcSEcCtD
Ciclesonide—Dyspepsia—Dexamethasone—multiple sclerosis	4.17e-05	0.000936	CcSEcCtD
Ciclesonide—Urticaria—Triamcinolone—multiple sclerosis	4.15e-05	0.000931	CcSEcCtD
Ciclesonide—Urticaria—Methylprednisolone—multiple sclerosis	4.14e-05	0.000929	CcSEcCtD
Ciclesonide—Dysgeusia—Methotrexate—multiple sclerosis	4.14e-05	0.000929	CcSEcCtD
Ciclesonide—Nausea—Mitoxantrone—multiple sclerosis	4.11e-05	0.000923	CcSEcCtD
Ciclesonide—Infection—Prednisone—multiple sclerosis	4.1e-05	0.00092	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	4.09e-05	0.000918	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	4.09e-05	0.000918	CcSEcCtD
Ciclesonide—Back pain—Methotrexate—multiple sclerosis	4.09e-05	0.000918	CcSEcCtD
Ciclesonide—Fatigue—Betamethasone—multiple sclerosis	4.09e-05	0.000917	CcSEcCtD
Ciclesonide—Fatigue—Dexamethasone—multiple sclerosis	4.09e-05	0.000917	CcSEcCtD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	4.08e-05	0.00731	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	4.08e-05	0.00731	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	4.02e-05	0.00721	CbGpPWpGaD
Ciclesonide—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	4.02e-05	0.00721	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	4e-05	0.00716	CbGpPWpGaD
Ciclesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	3.93e-05	0.00705	CbGpPWpGaD
Ciclesonide—Urticaria—Dexamethasone—multiple sclerosis	3.77e-05	0.000845	CcSEcCtD
Ciclesonide—Urticaria—Betamethasone—multiple sclerosis	3.77e-05	0.000845	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	3.76e-05	0.000844	CcSEcCtD
Ciclesonide—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	3.76e-05	0.00674	CbGpPWpGaD
Ciclesonide—Dizziness—Prednisolone—multiple sclerosis	3.76e-05	0.000843	CcSEcCtD
Ciclesonide—Asthenia—Triamcinolone—multiple sclerosis	3.75e-05	0.000841	CcSEcCtD
Ciclesonide—Asthenia—Methylprednisolone—multiple sclerosis	3.74e-05	0.000839	CcSEcCtD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	3.7e-05	0.00663	CbGpPWpGaD
Ciclesonide—Cough—Methotrexate—multiple sclerosis	3.69e-05	0.000828	CcSEcCtD
Ciclesonide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	3.66e-05	0.00656	CbGpPWpGaD
Ciclesonide—Dyspepsia—Prednisone—multiple sclerosis	3.64e-05	0.000816	CcSEcCtD
Ciclesonide—Chest pain—Methotrexate—multiple sclerosis	3.6e-05	0.000808	CcSEcCtD
Ciclesonide—Arthralgia—Methotrexate—multiple sclerosis	3.6e-05	0.000808	CcSEcCtD
Ciclesonide—Rash—Prednisolone—multiple sclerosis	3.58e-05	0.000804	CcSEcCtD
Ciclesonide—Dermatitis—Prednisolone—multiple sclerosis	3.58e-05	0.000803	CcSEcCtD
Ciclesonide—Fatigue—Prednisone—multiple sclerosis	3.56e-05	0.000799	CcSEcCtD
Ciclesonide—Headache—Prednisolone—multiple sclerosis	3.56e-05	0.000799	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	3.47e-05	0.00621	CbGpPWpGaD
Ciclesonide—Dizziness—Triamcinolone—multiple sclerosis	3.46e-05	0.000775	CcSEcCtD
Ciclesonide—Dizziness—Methylprednisolone—multiple sclerosis	3.45e-05	0.000774	CcSEcCtD
Ciclesonide—CES1—E2F transcription factor network—MYC—multiple sclerosis	3.44e-05	0.00616	CbGpPWpGaD
Ciclesonide—Infection—Methotrexate—multiple sclerosis	3.43e-05	0.000769	CcSEcCtD
Ciclesonide—Asthenia—Betamethasone—multiple sclerosis	3.4e-05	0.000763	CcSEcCtD
Ciclesonide—Asthenia—Dexamethasone—multiple sclerosis	3.4e-05	0.000763	CcSEcCtD
Ciclesonide—Nausea—Prednisolone—multiple sclerosis	3.38e-05	0.000757	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	3.37e-05	0.00604	CbGpPWpGaD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	3.33e-05	0.00597	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.31e-05	0.00593	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.31e-05	0.00593	CbGpPWpGaD
Ciclesonide—Rash—Triamcinolone—multiple sclerosis	3.3e-05	0.000739	CcSEcCtD
Ciclesonide—Dermatitis—Triamcinolone—multiple sclerosis	3.29e-05	0.000739	CcSEcCtD
Ciclesonide—Rash—Methylprednisolone—multiple sclerosis	3.29e-05	0.000738	CcSEcCtD
Ciclesonide—Dermatitis—Methylprednisolone—multiple sclerosis	3.29e-05	0.000737	CcSEcCtD
Ciclesonide—Urticaria—Prednisone—multiple sclerosis	3.28e-05	0.000736	CcSEcCtD
Ciclesonide—Headache—Triamcinolone—multiple sclerosis	3.27e-05	0.000735	CcSEcCtD
Ciclesonide—Headache—Methylprednisolone—multiple sclerosis	3.27e-05	0.000733	CcSEcCtD
Ciclesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	3.24e-05	0.0058	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	3.17e-05	0.00568	CbGpPWpGaD
Ciclesonide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.14e-05	0.000705	CcSEcCtD
Ciclesonide—Dizziness—Betamethasone—multiple sclerosis	3.14e-05	0.000704	CcSEcCtD
Ciclesonide—Dizziness—Dexamethasone—multiple sclerosis	3.14e-05	0.000704	CcSEcCtD
Ciclesonide—Nausea—Triamcinolone—multiple sclerosis	3.1e-05	0.000696	CcSEcCtD
Ciclesonide—Nausea—Methylprednisolone—multiple sclerosis	3.1e-05	0.000695	CcSEcCtD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	3.08e-05	0.00553	CbGpPWpGaD
Ciclesonide—Dyspnoea—Methotrexate—multiple sclerosis	3.08e-05	0.00069	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	3.06e-05	0.00548	CbGpPWpGaD
Ciclesonide—Dyspepsia—Methotrexate—multiple sclerosis	3.04e-05	0.000682	CcSEcCtD
Ciclesonide—Rash—Dexamethasone—multiple sclerosis	2.99e-05	0.000671	CcSEcCtD
Ciclesonide—Rash—Betamethasone—multiple sclerosis	2.99e-05	0.000671	CcSEcCtD
Ciclesonide—Dermatitis—Betamethasone—multiple sclerosis	2.99e-05	0.00067	CcSEcCtD
Ciclesonide—Dermatitis—Dexamethasone—multiple sclerosis	2.99e-05	0.00067	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	2.98e-05	0.000668	CcSEcCtD
Ciclesonide—Fatigue—Methotrexate—multiple sclerosis	2.98e-05	0.000668	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	2.97e-05	0.00533	CbGpPWpGaD
Ciclesonide—Headache—Betamethasone—multiple sclerosis	2.97e-05	0.000666	CcSEcCtD
Ciclesonide—Headache—Dexamethasone—multiple sclerosis	2.97e-05	0.000666	CcSEcCtD
Ciclesonide—Asthenia—Prednisone—multiple sclerosis	2.96e-05	0.000665	CcSEcCtD
Ciclesonide—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	2.92e-05	0.00524	CbGpPWpGaD
Ciclesonide—Nausea—Dexamethasone—multiple sclerosis	2.82e-05	0.000632	CcSEcCtD
Ciclesonide—Nausea—Betamethasone—multiple sclerosis	2.82e-05	0.000632	CcSEcCtD
Ciclesonide—Urticaria—Methotrexate—multiple sclerosis	2.74e-05	0.000615	CcSEcCtD
Ciclesonide—Dizziness—Prednisone—multiple sclerosis	2.73e-05	0.000613	CcSEcCtD
Ciclesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	2.69e-05	0.00482	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	2.69e-05	0.00481	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	2.69e-05	0.00481	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.65e-05	0.00475	CbGpPWpGaD
Ciclesonide—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.65e-05	0.00475	CbGpPWpGaD
Ciclesonide—Rash—Prednisone—multiple sclerosis	2.6e-05	0.000584	CcSEcCtD
Ciclesonide—Dermatitis—Prednisone—multiple sclerosis	2.6e-05	0.000584	CcSEcCtD
Ciclesonide—Headache—Prednisone—multiple sclerosis	2.59e-05	0.00058	CcSEcCtD
Ciclesonide—Asthenia—Methotrexate—multiple sclerosis	2.48e-05	0.000556	CcSEcCtD
Ciclesonide—Nausea—Prednisone—multiple sclerosis	2.45e-05	0.00055	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	2.4e-05	0.0043	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	2.36e-05	0.00423	CbGpPWpGaD
Ciclesonide—Dizziness—Methotrexate—multiple sclerosis	2.28e-05	0.000512	CcSEcCtD
Ciclesonide—Rash—Methotrexate—multiple sclerosis	2.18e-05	0.000488	CcSEcCtD
Ciclesonide—Dermatitis—Methotrexate—multiple sclerosis	2.17e-05	0.000488	CcSEcCtD
Ciclesonide—Headache—Methotrexate—multiple sclerosis	2.16e-05	0.000485	CcSEcCtD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	2.16e-05	0.00387	CbGpPWpGaD
Ciclesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	2.1e-05	0.00377	CbGpPWpGaD
Ciclesonide—Nausea—Methotrexate—multiple sclerosis	2.05e-05	0.00046	CcSEcCtD
Ciclesonide—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	2.04e-05	0.00365	CbGpPWpGaD
Ciclesonide—CES1—NRF2 pathway—TGFB1—multiple sclerosis	1.97e-05	0.00353	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.91e-05	0.00343	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.89e-05	0.00339	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.83e-05	0.00327	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.81e-05	0.00325	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.81e-05	0.00325	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.8e-05	0.00322	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.76e-05	0.00315	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.76e-05	0.00315	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.73e-05	0.0031	CbGpPWpGaD
Ciclesonide—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.73e-05	0.0031	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.71e-05	0.00307	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.66e-05	0.00297	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.6e-05	0.00286	CbGpPWpGaD
Ciclesonide—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.45e-05	0.00259	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.42e-05	0.00254	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.41e-05	0.00253	CbGpPWpGaD
Ciclesonide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.4e-05	0.00251	CbGpPWpGaD
Ciclesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.26e-05	0.00226	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.26e-05	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.26e-05	0.00225	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.22e-05	0.00219	CbGpPWpGaD
Ciclesonide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.14e-05	0.00204	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.13e-05	0.00203	CbGpPWpGaD
Ciclesonide—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	1.06e-05	0.00191	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	9.92e-06	0.00178	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	9.58e-06	0.00172	CbGpPWpGaD
Ciclesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	9.38e-06	0.00168	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—STAT3—multiple sclerosis	9.29e-06	0.00166	CbGpPWpGaD
Ciclesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.17e-06	0.00164	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	8.61e-06	0.00154	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—TNF—multiple sclerosis	8.04e-06	0.00144	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	7.93e-06	0.00142	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PABPC1—multiple sclerosis	7.69e-06	0.00138	CbGpPWpGaD
Ciclesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.44e-06	0.00133	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.95e-06	0.00125	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—RPL5—multiple sclerosis	6.94e-06	0.00124	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—SRM—multiple sclerosis	6.52e-06	0.00117	CbGpPWpGaD
Ciclesonide—NR3C1—Adipogenesis—IL6—multiple sclerosis	6.49e-06	0.00116	CbGpPWpGaD
Ciclesonide—CYP2D6—Biological oxidations—POMC—multiple sclerosis	6.04e-06	0.00108	CbGpPWpGaD
Ciclesonide—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.61e-06	0.00101	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—PGR—multiple sclerosis	5.46e-06	0.000979	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.59e-06	0.000823	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.59e-06	0.000823	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—SRM—multiple sclerosis	4.26e-06	0.000764	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—GPC5—multiple sclerosis	4.2e-06	0.000753	CbGpPWpGaD
Ciclesonide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.95e-06	0.000708	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—VDR—multiple sclerosis	3.82e-06	0.000684	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.48e-06	0.000624	CbGpPWpGaD
Ciclesonide—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	3.15e-06	0.000565	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	3e-06	0.000538	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	3e-06	0.000538	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.75e-06	0.000492	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.28e-06	0.000408	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—BCHE—multiple sclerosis	2e-06	0.000358	CbGpPWpGaD
Ciclesonide—NR3C1—Gene Expression—MYC—multiple sclerosis	1.52e-06	0.000272	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.31e-06	0.000234	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—APOE—multiple sclerosis	1.2e-06	0.000216	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—POMC—multiple sclerosis	1.03e-06	0.000185	CbGpPWpGaD
Ciclesonide—CYP2D6—Metabolism—ALB—multiple sclerosis	9.42e-07	0.000169	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—APOE—multiple sclerosis	7.86e-07	0.000141	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—POMC—multiple sclerosis	6.76e-07	0.000121	CbGpPWpGaD
Ciclesonide—CYP3A4—Metabolism—ALB—multiple sclerosis	6.16e-07	0.00011	CbGpPWpGaD
